Form 8-K - Current report:
SEC Accession No. 0001513162-21-000162
Filing Date
2021-12-16
Accepted
2021-12-16 08:49:48
Documents
15
Period of Report
2021-12-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bmra-20211216.htm   iXBRL 8-K 36577
2 EXHIBIT 99.1 exhibit99_1.htm EX-99.1 14947
3 GRAPHIC logo.jpg GRAPHIC 5491
  Complete submission text file 0001513162-21-000162.txt   187243

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20211216.xsd EX-101.SCH 3215
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20211216_def.xml EX-101.DEF 9490
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20211216_lab.xml EX-101.LAB 19000
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20211216_pre.xml EX-101.PRE 9729
8 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20211216_htm.xml XML 2204
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 211496113
SIC: 2835 In Vitro & In Vivo Diagnostic Substances